Abstract
We have studied 37 patients with advanced head and neck cancer. A combination of Cis-Platinum and 5-Fluorouracil, both administered four days continuously as infusion, was assessed. There were 15 complete responses (40.5%), 15 partial responses (40.5%) and the number of objective responses was 30 (81.5%). Survival is 79.1% at 22 months and none of the patients in complete responses has relapsed during this period.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Combined Modality Therapy
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Follow-Up Studies
-
Head and Neck Neoplasms / drug therapy*
-
Head and Neck Neoplasms / pathology
-
Humans
-
Middle Aged
-
Neoplasm Staging
-
Prospective Studies
-
Remission Induction